Top Markets
Coin of the day
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.

Poniard Pharmaceuticals, Inc.

PARD
Rang in Aktien #42764
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the... Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and market introduction of cancer treatments. Its flagship product candidate, Picoplatin, is a platinum-based therapy targeting various cancer types, such as small cell lung, colorectal, prostate, and ovarian cancers. The company has advanced Picoplatin through several clinical stages, including a pivotal Phase III SPEAR trial for small cell lung cancer patients in a second-line treatment setting. Furthermore, Phase II studies investigated Picoplatin as an initial therapy for metastatic colorectal cancer and hormone-refractory prostate cancer. An early-stage Phase I trial also examined an oral formulation of Picoplatin for solid tumors. Founded in 1984 as NeoRx Corporation, the company rebranded to Poniard Pharmaceuticals, Inc. in September 2006 and operates from its base in Seattle, Washington.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$150.00
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Poniard Pharmaceuticals, Inc. (PARD)

Kategorie

Kursverlauf für Poniard Pharmaceuticals, Inc. (PARD)
Höchster Schlusskurs: $0.00 am 2026-08-01

Niedrigster Schlusskurs: $1.69K am 1988-08-01
Kursverlauf der Aktie von Poniard Pharmaceuticals, Inc. von 1988 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 0.00%
2025 0.00%
2024 0.00%
2023 -99.00%
2022 0.00%
2021 -73.59%
2020 68.39%
2019 -58.15%
2018 0.25%
2017 -41.00%
2016 2.48%
2015 -45.77%
2014 -26.13%
2013 -32.03%
2012 -90.08%
2011 -82.25%
2010 -77.28%
2009 282.90%
2008 -55.38%
2007 -20.51%
2006 12.16%
2005 -57.29%
2004 -54.54%
2003 688.74%
2002 -88.91%
2001 -12.65%
2000 77.36%
1999 162.56%
1998 -76.29%
1997 24.18%
1996 -29.30%
1995 19.35%
1994 -39.86%
1993 -35.31%
1992 -11.37%
1991 687.42%
1990 -85.32%
1989 -41.53%
1988 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$526.77 35.85%
US
$874.00 37.08%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR